Skip to main content

Table 8 Classification results of A2, AG, MM for the independent test set, varying the number of extracted features.

From: Non-negative matrix factorisation methods for the spectral decomposition of MRS data from human brain tumours

PC/SS

LTE. PCA

LTE. Convex-NMF

STE. PCA

STE. Convex-NMF

2

Total:54.7%(29/53)

Total:54.7%(29/53)

Total:73.6%(39/53)

Total:71.7%(38/53)

 

A2:60.0%(6/10)

A2:60.0%(6/10)

A2:90.0%(9/10)

A2:60.0%(6/10)

 

AG:52.5% (21/40)

AG:50.0%(20/40)

AG:67.5%(27/40)

AG:72.5% (29/40)

 

MM:66.7% (2/3)

MM:100% (3/3)

MM:100% (3/3)

MM:100% (3/3)

 

BER:0.40

BER:0.30

BER:0.14

BER:0.23

3

Total: 60.4%(32/53)

Total:52.8%(28/53)

Total:69.8%(37/53)

Total:75.5%(40/53)

 

A2:70.0%(7/10)

A2:60.0%(6/10)

A2:80.0%(8/10)

A2:80.0%(8/10)

 

AG:55.0% (22/40)

AG:50.0%(20/40)

AG:65.0%(26/40)

AG:75.0%(30/40)

 

MM:100% (3/3)

MM:66.7% (2/3)

MM:100% (3/3)

MM:66.7% (2/3)

 

BER:0.25

BER:0.41

BER:0.18

BER:0.26

4

Total:67.9%(36/53)

Total:64.2%(34/53)

Total:73.6%(39/53)

Total:83.0%(44/53)

 

A2:80%(8/10)

A2:60.0%(6/10)

A2:70.0%(7/10)

A2:90.0%(9/10)

 

AG:62.5%(25/40)

AG:62.5%(25/40)

AG:72.5%(29/40)

AG:80%(32/40)

 

MM:100%(3/3)

MM:100%(3/3)

MM:100%(3/3)

MM:100%(3/3)

 

BER:0.19

BER:0.26

BER:0.19

BER:0.10

5

Total:67.9%(36/53)

Total:75.5%(40/53)

Total:73.6%(39/53)

Total:79.2%(42/53)

 

A2:80%(8/10)

A2:70.0%(7/10)

A2:70.0%(7/10)

A2:80.0%(8/10)

 

AG:62.5%(25/40)

AG:75.0%(30/40)

AG:72.5%(29/40)

AG:77.5%(31/40)

 

MM:100%(3/3)

MM:100%(3/3)

MM:100%(3/3)

MM:100%(3/3)

 

BER:0.19

BER:0.18

BER:0.19

BER:0.14

6

Total:67.9%(36/53)

Total:73.6%(39/53)

Total:79.2%(42/53)

Total:83.0%(44/53)

 

A2:80%(8/10)

A2:70.0%(7/10)

A2:70.0%(7/10)

A2:90.0%(9/10)

 

AG:62.5%(25/40)

AG:72.5%(29/40)

AG:82.5%(33/40)

AG:82.5%(33/40)

 

MM:100%(3/3)

MM:100%(3/3)

MM:66.7%(2/3)

MM:66.7%(2/3)

 

BER:0.19

BER:0.19

BER:0.27

BER:0.20

7

Total:67.9%(36/53)

Total:73.6%(39/53)

Total:79.2%(42/53)

Total:83.0%(44/53)

 

A2:80%(8/10)

A2:70.0%(7/10)

A2:70.0%(7/10)

A2:90.0%(9/10)

 

AG:62.5%(25/40)

AG:72.5%(29/40)

AG:82.5%(33/40)

AG:82.5%(33/40)

 

MM:100%(3/3)

MM:100%(3/3)

MM:66.7%(2/3)

MM:66.7%(2/3)

 

BER:0.19

BER:0.19

BER:0.27

BER:0.20

8

Total:75.5%(40/53)

Total:69.8%(37/53)

Total:81.1%(43/53)

Total:84.9%(45/53)

 

A2:80%(8/10)

A2:70.0%(7/10)

A2:80%(8/10)

A2:90.0%(9/10)

 

AG:72.5%(29/40)

AG:67.5%(27/40)

AG:80%(32/40)

AG:85%(34/40)

 

MM:100%(3/3)

MM:100%(3/3)

MM:100%(3/3)

MM:66.7%(2/3)

 

BER:0.16

BER:0.21

BER:0.13

BER:0.19

9

Total:75.5%(40/53)

Total:71.7%(38/53)

Total:84.9%(45/53)

Total:86.8%(46/53)

 

A2:80%(8/10)

A2:70.0%(7/10)

A2:90%(9/10)

A2:90%(9/10)

 

AG:72.5%(29/40)

AG:70.0%(28/40)

AG:82.5%(33/40)

AG:87.5%(35/40)

 

MM:100%(3/3)

MM:100%(3/3)

MM:100%(3/3)

MM:66.7%(2/3)

 

BER:0.16

BER:0.20

BER:0.09

BER:0.19

10

Total:73.6%(39/53)

Total:69.8%(37/53)

Total:86.8%(46/53)

Total:84.9%(45/53)

 

A2:80%(8/10)

A2:70.0%(7/10)

A2:90%(9/10)

A2:90.0%(9/10)

 

AG:70%(28/40)

AG:67.5%(27/40)

AG:85%(34/40)

AG:85%(34/40)

 

MM:100%(3/3)

MM:100%(3/3)

MM:100%(3/3)

MM:66.7%(2/3)

 

BER:0.17

BER:0.21

BER:0.08

BER:0.19

  1. Classification accuracies (total and by tumour type) and BER for the independent test set, at LTE and STE, using the corresponding classification settings from Table 7. The second and fourth columns show the results for PCA, and the third and fifth columns the results for Convex-NMF